We don’t know when (ex­act­ly) Lil­ly will an­nounce the FDA’s baric­i­tinib de­ci­sion, but watch out for the loom­ing pric­ing squab­ble

Some­time in the next few days, the FDA will be right on the PDU­FA de­ci­sion dead­line for baric­i­tinib. We just don’t know which day.

For some rea­son, Eli Lil­ly $LLY has de­cid­ed to keep the dead­line un­der wraps, as con­firmed yes­ter­day by a spokesper­son for the com­pa­ny. It could be tonight, ahead of a long hol­i­day week­end in the US. It could be to­mor­row. They could even wait un­til Mon­day, af­ter the de­ci­sion is for­mal, to roll out their an­nounce­ment.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

Vice President

Alexandria Real Estate Equities

San Francisco, CA, USA